| Bioactivity | Cap-dependent endonuclease-IN-5 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-5 inhibits influenza virus well, and/or has lower cytotoxicity, better in vivo pharmacokinetic properties and in vivo pharmacodynamic properties (extracted from patent WO2020078401A1, compound 13-1)[1]. |
| Name | Cap-dependent endonuclease-IN-5 |
| CAS | 2416258-53-0 |
| Formula | C27H21F2N3O4S2 |
| Molar Mass | 553.60 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Huichao LUO, et al. Influenza virus replication inhibitor and uses thereof. Patent WO2020078401A1. |
Cap-dependent endonuclease-IN-5
CAS: 2416258-53-0 F: C27H21F2N3O4S2 W: 553.60
Cap-dependent endonuclease-IN-5 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.